706
Views
50
Crossref
N/A
WoS
42
Scopus
3
CSCD
The genome editing tool, clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, has achieved successful therapeutic efficacy via precise modification of the genome and exceeded previous genome engineering methods owing to its versatility and simplicity. Rapid expansion in biomedical research has benefited from this newly emerged technique, such as genetic diseases treatment, cancer characterization, and plant improvement. However, the key challenge is efficient delivery of CRISPR components in vivo and nanotechnology plays an indispensable role in nonviral gene delivery. In this review, we will first briefly describe the mechanism and delivery strategies of CRISPR/Cas9 system. Furthermore, the past and current researches of nanoparticles based CRISPR/Cas9 system delivery for genome editing will be highlighted. Finally, we will discuss the challenges and prospects of CRISPR/Cas9 system combined with nanotechnology for clinical translation in the future.
This work was supported by the National Natural Science Foundation of China (Nos. 81673374 and 81872810), Wuhan Science and Technology Plan for Applied Fundamental Research (No. 2017060201010146), and Fundamental Research Funds for the Central Universities (No. 2018KFYYXJJ019).